English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Mar 11, 2026

Study links positive views on aging to better long-term health outcomes

Patient Daily | Mar 11, 2026

Salk scientists find key protein linking GLP-1 drug benefits to pancreatic cell health

Patient Daily | Mar 11, 2026

How evolution within human tissues shapes disease risk and reveals new drug targets

Patient Daily | Mar 11, 2026

Northwestern Medicine Glenview Outpatient Center expands services after multiyear project

Patient Daily | Mar 10, 2026

Yale New Haven Hospital ranked among world’s best by Newsweek in 2026

Patient Daily | Mar 10, 2026

Baylor College of Medicine partners with Temple ISD and Baylor Scott & White on STEM+M program

Patient Daily | Mar 10, 2026

The Marcus Foundation awards $14.4 million to create Marcus VITAL Laboratory at Baylor College of Medicine’s Center for Aortic Surgery

Patient Daily | Mar 10, 2026

AAFA releases 2026 Allergy Capitals report highlighting climate and health concerns

Trending

+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift

Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks

Patient Daily | Apr 8, 2026

Breathe Free Teams Pack Meals at Community Volunteer Event, Expanding Care Beyond Clinics

+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'

  • « First
  • «
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily